Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial


SAİP P. M. , Eralp Y. , Sen F., Karaca H., ÖZKAN M., Cetin B., ...More

BREAST, vol.22, no.5, pp.628-633, 2013 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 5
  • Publication Date: 2013
  • Doi Number: 10.1016/j.breast.2013.07.048
  • Title of Journal : BREAST
  • Page Numbers: pp.628-633

Abstract

Background: The aim of this explorative phase II study was to evaluate the activity and safety of lapatinib in combination with intravenous vinorelbine in women with HER2 positive metastatic or recurrent breast cancer.